U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

Vertex stock trades at 23.8 times forward earnings (in line with the S&P 500), with $11.2 billion in cash and strong growth prospects. The healthcare sector has struggled to deliver worthwhile ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. BOSTON, January 27 ...

Vertex Pharmaceuticals Incorporated ... It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for ...

Boston got over 110 inches of snow during the historic 2015 winter — and that wasn't the only wild number. Here’s a look back ...

Fans of Radio 2 flocked to social media website X this morning ... I'm sure many of you have no idea about me at all. "Either way, if you could make me part of your morning routine, it would ...

Full of people fawning over him, it was all very childish and self indulgent. Radio 2 has really lost its way, they seem to have forgotten how to do radio & will continue to loose their audience. It ...

Scott Mills has admitted he is still struggling to process his new role as the host of BBC Radio 2’s primetime breakfast ... been working so hard right the way through the night to change ...